Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Trex Company, Inc. (“Trex” or the “Company”) (NYSE:TREX). The investigation...
-
Gauzy Ltd. Sets Date for Third Quarter 2025 Results
-
On Aug 14, 2025, Fly-E reported a 32% revenue drop and weak E-Bike sales tied to battery issues, causing its stock to plunge 87% from $7.76 to $1.00.
-
On May 27, 2025, Savara revealed the FDA refused to file its MOLBREEVI BLA due to insufficient CMC data, causing shares to fall $0.90, or 31.69%, to $1.94.
-
On Oct 24, 2025, Beyond Meat disclosed a material impairment charge, dropping shares 23%. On Nov 3, 2025, it delayed Q3 results, causing further decline.
-
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ:DXCM) securities to contact Thomas W. Elrod of Kirby...
-
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Camping World Holdings, Inc. (“Camping World” or the “Company”) (NYSE:CWH)....
-
Alvotech got an FDA Complete Response Letter for its AVT05 BLA after a failed July 2025 inspection; shares fell 34% to $5.03 on the news.
-
uniQure disclosed the FDA no longer agrees its AMT-130 trial data may support a BLA submission, making timing unclear. Shares fell over 57% on the news.
-
Allegedly, defendants hid unauthorized FDA design changes to DexCom’s G6 and G7, making them less reliable and exposing users to health risks.